Alec Sapir
CEO and President
Replay available
Fulcrum Therapeutics, Inc. (FULC) Q2 2024 Earnings Call
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Q2 2024 earnings conference call, held 2024-07-31. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Alan Musso
Chief Financial Officer
Dr. Pat Horn
Chief Medical Officer
Matthew Beigler
Analyst, OPCO
Kristen Khrushchev
Analyst, Cantor Fitzgerald
Corinne Johnson
Analyst, Goldman Sachs
Daegong Ha
Analyst, Stifel
Joseph Schwartz
Analyst, Leverick Partners
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fulcrum Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.300 Good morning and welcome to Fulcrum's Therapeutics Second Quarter 2024 00:00:05.300 -- 00:00:09.748 Financial Results and Business Update Conference Call. 00:00:09.748 -- 00:00:13.354 Currently, all participants are on a listen-only mode. 00:00:13.354 -- 00:00:18.563 This call is being webcast live and can be accessed on the investor section 00:00:18.563 -- 00:00:22.266 of Fulcrum's website at www.fulcrumtx.com 00:00:24.393 -- 00:00:27.074 and is being recorded. 00:00:27.233 -- 00:00:32.478 Please be reminded the remarks during this call may contain forward-looking statements 00:00:32.478 -- 00:00:36.743 within the meaning of the Private Securities Litigation Reform Act of 1995. 00:00:36.743 -- 00:00:38.785 May include 00:00:38.785 -- 00:00:43.688 statements about the company's future expectations and plans, 00:00:44.230 -- 00:00:47.994 timelines, and financial projections. 00:00:47.994 -- 00:00:54.298 While these forward-looking statements represent full-time views as of today, this 00:00:54.402 -- 00:00:59.548 should not be relied upon as representing the company's views in the future. 00:00:59.548 -- 00:01:04.734 Fulcrum may update these statements in the future, but is not taking on an 00:01:04.734 -- 00:01:07.257 obligation to do so. 00:01:07.257 -- 00:01:12.222 Please refer to Fulcrum's most recent filings with the Securities and Exchange Commission 00:01:12.222 -- 00:01:18.249 for discussion of certain risks and uncertainties associated with the company's business. 00:01:18.249 -- 00:01:22.033 Meeting today will be Alec Sapir, 00:01:22.033 -- 00:01:27.756 CEO and President of Fulcrum. Joining Alex on the call are Alan Musso, 00:01:27.756 -- 00:01:33.704 Chief Financial Officer, Dr. Pat Horn, Chief Medical Officer, and 00:01:...